Edition:
United States

People: Biocept Inc (BIOC.OQ)

BIOC.OQ on NASDAQ Stock Exchange Capital Market

1.02USD
18 Apr 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.02
Open
$1.01
Day's High
$1.04
Day's Low
$1.01
Volume
137,593
Avg. Vol
440,876
52-wk High
$12.12
52-wk Low
$0.66

Nall, Michael 

Mr. Michael W. Nall is President, Chief Executive Officer, Director of the Company. He has over 30 years of healthcare sales and marketing experience, serving as our CEO and President since 2013. Before joining Biocept, Mr. Nall served at Clarient Diagnostic Services, Inc. in positions of increasing responsibility from 2002 through August 2013, with his last position being General Manager, North American Sales and Marketing. While at Clarient, Mr. Nall was also responsible for leading the team assimilating Clarient into GE Healthcare after Clarient was acquired in 2010. From 1988 until joining Clarient, Mr. Nall served in the diagnostic and medical device industries in various commercial leadership roles for companies including Impath, American Cyanamid, Maquet Surgical, Strato Medical, Horizon Medical Products and Columbia Vital Systems. Mr. Nall received a Bachelor of Science degree in Business Administration from Central Missouri State University (now known as the University of Central Missouri).

Basic Compensation

Total Annual Compensation, USD 480,997
Restricted Stock Awards, USD 112,500
Long-Term Incentive Plans, USD --
All Other, USD 546,343
Fiscal Year Total, USD 1,139,840

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Hale

940,712

Michael Nall

1,139,840

Timothy Kennedy

622,437

Lyle Arnold

550,676

Edwin Hendrick

--

Michael Terry

--
As Of  30 Dec 2017